Colorectal cancer is one of the most treatable cancers, especially when detected early. For those in advanced stages, ...

Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...

Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly ...

Neuronetics' strategic acquisitions, including Greenbrook, and FDA approvals are expected to drive revenue growth. See why ...

Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics") is issuing this press release to update the reporting of its financial results for the ...

BioRestorative also continues to explore a first-in-human clinical trial for its ThermoStem ® metabolic platform technology. The Company derived $300,000 in revenue from BioCosmeceuticals in 2024.

ABIVAX is a French biotech with a novel ulcerative colitis treatment in phase 3 trials. Click here to find out why I am ...

Silexion's new expanded dual-route strategy will integrate intratumoral and systemic administration to target both primary ...

Beginning July 1, social workers in Peoria Unified will need to have taken two exams to meet license requirements.

Abstract accepted for late-breaking poster presentation – -- EO-1022 is a potentially differentiated HER3 ADC being developed for the treatment of solid ...

Q4 2024 Earnings Call Transcript March 27, 2025 GeoVax Labs, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.79. Operator: Good afternoon. And welcome everyone to the ...

New non-clinical data strengthens evidence of contributions of IO102 and IO103 to tumor growth control through target specific T-cell ...